Can Creatine and BCAAs Support Energy and Muscle Recovery in Long COVID and ME/CFS?

To understand the foundational role of creatine, we must first look at how the body generates energy at the microscopic level. Adenosine triphosphate (ATP) is the primary energy currency of every cell in the human body. However, the baseline concentration of ATP stored within skeletal muscle and brain tissue is remarkably small—only enough to sustain peak cellular activity for a few seconds. When a cell uses ATP for energy, it cleaves off a phosphate molecule, converting ATP into adenosine diphosphate (ADP). To maintain ongoing energy production, the cell must rapidly reattach a phosphate to ADP, regenerating it back into ATP. This is where the ATP-Phosphocreatine (ATP-PCr) system becomes essential. Creatine is a naturally occurring organic compound synthesized in the liver and kidneys from the amino acids arginine, glycine, and methionine. Once synthesized or ingested, it travels to high-energy-demanding tissues like skeletal muscle and the brain, where it is stored as phosphocreatine (PCr).

Phosphocreatine acts as a rapidly mobilizable reserve of high-energy phosphates. Through an enzymatic reaction catalyzed by creatine kinase, phosphocreatine donates its phosphate group to ADP, instantly resynthesizing ATP without the need for oxygen or glucose metabolism. This mechanism, detailed in physiological reviews, allows cells to maintain energy output during sudden spikes in demand. Furthermore, this reaction consumes a hydrogen ion (H+), acting as an intracellular buffer that prevents the rapid accumulation of localized cellular acidity, thereby delaying neuromuscular fatigue. In a healthy body, this system ensures that muscles can contract forcefully and neurons can fire rapidly without immediate exhaustion.

While creatine provides the immediate energy for cellular work, branched-chain amino acids (BCAAs) provide the structural and signaling components necessary for tissue repair and maintenance. The BCAAs consist of three essential amino acids: leucine, isoleucine, and valine. Unlike other amino acids, which are primarily metabolized in the liver, BCAAs bypass hepatic metabolism and are oxidized directly within skeletal muscle. This unique metabolic pathway allows them to serve as a rapid, alternative energy source during prolonged physical exertion when glycogen stores are depleted. More importantly, BCAAs act as powerful molecular signals that regulate muscle protein turnover.

Among the three BCAAs, L-leucine is recognized as the master nutritional trigger for muscle protein synthesis (MPS). Leucine operates as an intracellular signaling molecule that activates the mTORC1 (mechanistic Target of Rapamycin Complex 1) pathway, the central regulator of cell growth and protein translation. According to research from the Sabatini Lab, leucine binds to an intracellular sensor called Sestrin2. This binding initiates a complex molecular relay involving GATOR proteins and Rag GTPases, ultimately recruiting mTORC1 to the lysosome where it becomes fully activated. Once activated, mTORC1 phosphorylates downstream targets that initiate the translation of mRNA into new muscle proteins, effectively shifting the body from a catabolic (tissue-breaking) state to an anabolic (tissue-building) state.

Thorne's Creatine + BCAAs formula also includes L-glutamine, the most abundant amino acid in the human body. While typically considered a "non-essential" amino acid because the body can synthesize it, glutamine becomes "conditionally essential" during periods of severe physiological stress, chronic illness, or viral infection. Glutamine serves as the primary metabolic fuel for enterocytes, the cells that line the small intestine. It is required to maintain the integrity of the intestinal mucosal barrier, ensuring that the "tight junctions" between cells remain closed, preventing the leakage of undigested food particles and pathogens into the bloodstream.

Beyond the gut, glutamine is indispensable for the immune system. Immune cells, including lymphocytes, macrophages, and neutrophils, rely heavily on glutamine for rapid proliferation and nucleotide synthesis when mounting a defense against pathogens. Furthermore, glutamine is a crucial precursor for the synthesis of glutathione, the body's master intracellular antioxidant. By driving glutathione production, glutamine protects immune cells from the oxidative stress they generate during inflammatory responses, as highlighted in immunological research. Together, these ingredients form a comprehensive network that supports energy production, structural integrity, and immune resilience.

In conditions like Long COVID and ME/CFS, the fundamental mechanisms of cellular energy production become profoundly disrupted. Research increasingly points to mitochondrial dysfunction as a core driver of the debilitating fatigue and post-exertional malaise experienced by patients. Viral infections, such as SARS-CoV-2, can directly damage mitochondria or trigger a chronic, hyper-inflammatory state that impairs their ability to efficiently produce ATP through oxidative phosphorylation. When the mitochondria falter, the body is forced to rely heavily on less efficient, anaerobic energy pathways, leading to a rapid depletion of intracellular ATP and an accumulation of metabolic byproducts like lactic acid.

This bioenergetic crisis is further compounded by a measurable depletion of the body's natural creatine stores. Studies have shown that patients suffering from post-viral fatigue syndromes often exhibit significantly lower levels of creatine and phosphocreatine in both their skeletal muscles and central nervous system. Without adequate phosphocreatine reserves, the ATP-PCr system cannot rapidly regenerate ATP during physical or cognitive exertion. This cellular energy deficit directly translates to the clinical presentation of PEM: a state where even minor activities drain the cellular battery entirely, requiring days or weeks of severe rest to partially recharge.

The profound fatigue and exercise intolerance inherent in these conditions often lead to prolonged periods of bed rest and reduced physical activity. Over time, this forced inactivity triggers a secondary, yet equally devastating complication: severe physical deconditioning and muscle atrophy. When muscles are not regularly engaged, the body downregulates muscle protein synthesis and upregulates muscle protein breakdown, leading to a loss of lean body mass. This catabolic state is exacerbated by the chronic systemic inflammation often seen in Long COVID and ME/CFS, which blunts the muscle's sensitivity to anabolic signals like insulin and dietary amino acids.

For patients with comorbid dysautonomia, particularly Postural Orthostatic Tachycardia Syndrome (POTS), the loss of lean muscle mass in the lower extremities is particularly problematic. The cardiovascular system relies heavily on the "skeletal muscle pump"—the contraction of leg muscles—to push blood back up to the heart against gravity. When leg muscles atrophy, venous pooling increases, exacerbating orthostatic intolerance, dizziness, and tachycardia. The inability to maintain muscle mass due to the metabolic roadblocks of chronic illness creates a vicious cycle of worsening deconditioning and escalating dysautonomic symptoms.

The systemic impact of Long COVID and ME/CFS extends deeply into the gastrointestinal and immune systems. Acute viral infections can severely drain the host's systemic amino acid pools, leaving the immune system starved of its primary fuel sources. Metabolomic profiling of Long COVID patients has revealed persistent abnormalities, including significantly lower-than-normal plasma levels of key amino acids like glutamine. This depletion essentially removes the brakes from the immune system. Without enough glutamine to create glutathione, unchecked oxidative stress triggers the overproduction of pro-inflammatory cytokines, perpetuating systemic inflammation and vascular damage.

Furthermore, the depletion of glutamine compromises the intestinal barrier, leading to increased intestinal permeability, or "leaky gut." This allows endotoxins to enter the bloodstream, further driving systemic inflammation and microglial activation in the brain, which contributes to neuroinflammation and cognitive dysfunction. The interconnectedness of these systems means that a deficit in one area—such as cellular energy or amino acid availability—cascades into widespread physiological dysfunction, making recovery incredibly difficult without targeted nutritional intervention.

Supplementing with a high-quality formula like Thorne's Creatine + BCAAs directly addresses the bioenergetic deficits central to post-viral fatigue syndromes. By providing a highly bioavailable form of creatine monohydrate, supplementation forcefully expands the intracellular pool of total creatine and phosphocreatine. This expansion enhances the capacity of the ATP-PCr system to rapidly regenerate ATP during periods of cellular stress. For a patient with Long COVID or ME/CFS, this means that the cellular "battery" has a larger reserve capacity, potentially raising the threshold at which post-exertional malaise is triggered.

Beyond merely storing energy, creatine also acts as a crucial spatial buffer within the cell. The creatine kinase system shuttles high-energy phosphates from the mitochondria (where they are produced) to the cytoplasm and myofibrils (where they are utilized). In conditions where mitochondrial function is impaired, optimizing this shuttling mechanism ensures that whatever ATP is produced is efficiently delivered to the sites of cellular work. Additionally, because creatine is osmotically active, it draws water into the muscle cell. This cellular volumization acts as an anabolic signal, promoting cell survival and inhibiting the protein breakdown pathways that lead to muscle wasting.

The inclusion of BCAAs—specifically in the evidence-based 2:1:1 ratio of leucine, isoleucine, and valine—provides the necessary molecular signals and building blocks to combat deconditioning. By delivering a concentrated dose of L-leucine (2.5 grams per serving), this formula directly activates the mTORC1 pathway, flipping the metabolic switch from muscle breakdown to muscle repair. This is particularly crucial for patients experiencing "anabolic resistance" due to chronic inflammation, as a concentrated dose of leucine can override this resistance and stimulate muscle protein synthesis even in the absence of strenuous exercise.

Furthermore, BCAAs serve as a readily available, alternative energy source for skeletal muscle. During periods of exertion, when glucose metabolism may be impaired or oxygen delivery is compromised (as seen in the microvascular dysfunction of Long COVID), the muscle can oxidize isoleucine and valine directly for fuel. This spares muscle glycogen and reduces the accumulation of fatigue-inducing metabolites. By bridging the gap between energy output and structural repair, the combination of creatine and BCAAs helps patients maintain the lean muscle mass necessary to support joint stability, metabolic health, and the skeletal muscle pump vital for managing dysautonomia.

The benefits of this formula extend far beyond skeletal muscle. The brain is a highly metabolically active organ, consuming roughly 20% of the body's resting energy. During periods of cognitive exertion, sleep deprivation, or neuroinflammation, the brain relies heavily on the ATP-PCr system to maintain energy homeostasis. Supplementing with creatine has been shown to stabilize brain phosphocreatine levels and prevent cellular acidification, effectively acting as a neurological energy buffer. This mechanism is critical for combating the profound cognitive dysfunction, or "brain fog," that plagues patients with complex chronic illnesses, allowing for improved short-term memory, processing speed, and mental stamina.

Additionally, the inclusion of L-glutamine provides targeted support for the gut-immune axis. By replenishing depleted glutamine stores, the body can repair the intestinal mucosal barrier, reducing the systemic inflammation driven by leaky gut. Glutamine also fuels the rapid proliferation of immune cells and provides the necessary precursor for glutathione synthesis, enhancing the body's antioxidant defenses. This comprehensive approach ensures that the immune system has the resources it needs to regulate itself, reducing the chronic, low-grade inflammation that perpetuates the cycle of fatigue and cellular damage.

Based on the biochemical mechanisms of its ingredients, Thorne's Creatine + BCAAs may help manage several debilitating symptoms associated with complex chronic conditions:

When considering supplementation, the form and bioavailability of the ingredients are paramount. Thorne’s formula utilizes micronized creatine monohydrate. Creatine monohydrate is the most extensively researched and clinically validated form of creatine available. The "micronization" process involves mechanically dividing the creatine particles into a much smaller, finer powder. This significantly increases the surface area of the compound, leading to superior solubility in liquids and enhanced absorption in the gastrointestinal tract. This refined formulation dramatically reduces the likelihood of gastrointestinal discomfort, bloating, or cramping that is sometimes associated with standard, non-micronized creatine products.

For optimal absorption, creatine is best taken with a source of carbohydrates or a mixed meal. Insulin plays a key role in driving creatine into the skeletal muscle cells via the SLC6A8 transporter. Co-ingesting creatine with a carbohydrate source triggers an insulin spike, which significantly enhances the cellular uptake and retention of creatine. This is particularly relevant for patients with chronic illness who may already struggle with metabolic inefficiencies. The powdered format of Thorne's Creatine + BCAAs allows it to be easily mixed into water, juice, or a comprehensive recovery smoothie.

The dosing strategy for creatine depends heavily on the targeted outcome. To saturate skeletal muscle, a standard maintenance dose of 3 to 5 grams per day is highly effective. Thorne's formula provides exactly 5 grams of creatine monohydrate per serving, making it an ideal daily protocol for supporting physical endurance and muscle recovery. Some individuals choose to implement a "loading phase" of 20 grams per day (divided into four 5-gram doses) for 5-7 days to achieve rapid muscle saturation, though taking 5 grams daily will achieve the same saturation level over a period of about 28 days.

However, clinical research indicates that the blood-brain barrier is highly resistant to creatine transport. To effectively increase brain creatine levels and combat neurological symptoms like brain fog, higher doses are often required. Recent academic reviews suggest that protocols utilizing 10 to 20 grams per day may be necessary to achieve significant cognitive benefits. Patients utilizing this formula specifically for cognitive support should discuss appropriate, individualized dosing strategies with their healthcare provider, potentially utilizing multiple servings throughout the day to reach higher therapeutic thresholds.

Creatine monohydrate is one of the safest and most well-studied dietary supplements in existence. Decades of clinical data have thoroughly debunked the myth that standard creatine supplementation damages healthy kidneys. However, individuals with pre-existing renal disease or those taking nephrotoxic medications should consult a physician before use, as creatine does slightly elevate serum creatinine levels (a byproduct of creatine metabolism), which can confound standard kidney function blood tests. The product is contraindicated in individuals with a history of hypersensitivity to any of its ingredients and should not be used by pregnant or nursing women.

A specific caution must be noted regarding the L-glutamine content for patients with severe ME/CFS. While glutamine is vital for gut health, it exists in a delicate balance with glutamate, an excitatory neurotransmitter in the brain. Emerging research utilizing magnetic resonance spectroscopy has shown that some ME/CFS patients have abnormally high levels of glutamine/glutamate in their brains, indicating neuroinflammation and potential excitotoxicity. For these specific individuals, adding exogenous glutamine could theoretically exacerbate sensory overload or the "wired but tired" feeling. Therefore, ME/CFS patients should introduce this supplement slowly and monitor their neurological symptoms closely under the guidance of a medical professional.

The scientific consensus regarding creatine has expanded rapidly in recent years, moving beyond sports performance to highlight its profound therapeutic potential for post-viral syndromes. A pivotal 2023 randomized, placebo-controlled trial published in Food Science & Nutrition investigated the effects of creatine monohydrate on patients with moderate Long COVID symptoms. Participants received 4 grams of creatine daily for 6 months. The results were striking: the creatine group experienced a significant reduction in general fatigue after just 3 months. By the 6-month mark, patients reported statistically significant improvements in debilitating symptoms, including body aches, headaches, and difficulties concentrating, with researchers noting zero major side effects.

Building on this, a 2024 trial published in the Journal of Nutritional Science and Vitaminology explored the co-administration of creatine and glucose in Long COVID patients over 8 weeks. The group receiving 8 grams of creatine alongside glucose demonstrated massive improvements in physical endurance, measured by a treadmill time-to-exhaustion test. Furthermore, they experienced large effect-size reductions in severe body aches and cognitive difficulties. Most recently, data presented at the 2025 European Respiratory Society Congress showed that a 6g/day dose of creatine combined with light physical activity significantly improved objective handgrip strength and reduced fatigue scores in Long COVID patients over just 4 weeks.

The impact of creatine on cognitive function under metabolic stress has been robustly validated by recent clinical data. A landmark 2024 double-blind, placebo-controlled crossover trial published in Scientific Reports investigated creatine's ability to rescue cognitive function during severe sleep deprivation. Participants given a high acute dose (0.35g/kg of body weight) showed statistically significant improvements in short-term memory, processing speed, and logical task execution compared to the placebo group. Brain scans confirmed that the creatine stabilized brain phosphocreatine levels and prevented cellular acidification, effectively neutralizing the metabolic origins of brain fog.

This acute data is supported by a comprehensive 2024 systematic review and meta-analysis published in Frontiers in Nutrition, which analyzed 24 studies encompassing over 1,000 participants. The meta-analysis concluded with "moderate certainty" that creatine supplementation significantly improves memory function and information processing speed in adults. Crucially, the researchers noted that creatine is particularly beneficial when the brain is under metabolic stress or deficit, making it a highly relevant intervention for the neuroinflammation and energy crises seen in complex chronic illnesses.

The clinical efficacy of BCAAs, particularly leucine, in stimulating muscle protein synthesis is well-established. A landmark study by Churchward-Venne et al. demonstrated the "leucine threshold" concept. Researchers found that supplementing a suboptimal dose of protein (6.25g) with extra leucine to reach a total of 3 grams stimulated resting muscle protein synthesis just as effectively as a massive 25g dose of whey protein. This highlights the unparalleled signaling power of leucine in overcoming anabolic resistance, a critical factor for patients battling the muscle-wasting effects of chronic inflammation and prolonged bed rest.

Regarding L-glutamine, metabolomic profiling of Long COVID patients has consistently revealed severe systemic amino acid depletion. Studies from the University of Alberta found that Long COVID patients with the lowest plasma levels of glutamine, serine, and sarcosine were the most likely to report severe clinical depression, anxiety, and profound fatigue. This data underscores the critical need for targeted amino acid replenishment to restore the gut-immune axis, support glutathione production, and provide the foundational fuel required for immune system regulation and cellular repair.

Living with a complex chronic condition like Long COVID, ME/CFS, or dysautonomia often feels like a constant battle against an invisible, draining force. The profound exhaustion, the unpredictable crashes, and the frustrating brain fog are not simply signs of being "tired"—they are the clinical manifestations of a body struggling to produce and manage cellular energy at a fundamental level. Validating this reality is the first step toward effective management. While there are no quick fixes for these intricate illnesses, understanding the biochemical pathways that drive your symptoms empowers you to make targeted, science-backed decisions about your health.

Thorne’s Creatine + BCAAs offers a comprehensive, evidence-based approach to supporting the very systems that chronic illness disrupts. By replenishing the ATP-PCr energy system, triggering muscle protein synthesis, and providing vital fuel for the gut-immune axis, this formula addresses multiple facets of post-viral fatigue and deconditioning. However, supplements are most effective when integrated into a holistic management strategy that includes aggressive pacing, symptom tracking, and comprehensive medical care. If you are struggling to maintain your energy envelope or protect your physical strength, this targeted combination of cellular bioenergetics and structural support may be a valuable addition to your protocol.

Disclaimer: The information provided in this blog is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement regimen, especially if you have been diagnosed with a complex chronic condition, are taking prescription medications, or have underlying kidney or neurological issues.